Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald T Moir

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Current Drug Targets. Infectious Disorders|September 27, 2005
Identification of inhibitors of bacterial enoyl-acyl carrier protein reductaseDonald T Moir
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2016
Beyond Antibiotics: New Therapeutic Approaches for Bacterial InfectionsAlan R Hauser, Joan Mecsas, Donald T Moir
Expert Opinion on Therapeutic Targets|July 30, 2003
Microbial pathogen genomes - new strategies for identifying therapeutic and vaccine targetsTimothy Opperman, Losee L Ling, Donald T Moir
Current Opinion in Pharmacology|July 31, 2012
New classes of antibioticsDonald T Moir, Timothy J Opperman, Michelle M Butler, et al.
Journal of Bacteriology|October 22, 2008
An essential DnaB helicase of Bacillus anthracis: identification, characterization, and mechanism of actionEsther E Biswas, Marjorie H Barnes, Donald T Moir, et al.
Drug Discovery Today|April 12, 2021
Adjunctive therapy for multidrug-resistant bacterial infections: Type III secretion system and efflux inhibitorsDonald T Moir, Timothy J Opperman, Zachary D Aron, et al.
Journal of Biomolecular Screening|July 24, 2007
A high-throughput, homogeneous, bioluminescent assay for Pseudomonas aeruginosa gyrase inhibitors and other DNA-damaging agentsDonald T Moir, Ming Di, Timothy Opperman, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 6, 2009
Cellular reporter screens for inhibitors of Burkholderia pseudomallei targets in Pseudomonas aeruginosaDonald T Moir, Ming Di, Richard A Moore, et al.
Molecules (Basel, Switzerland)|January 4, 2011
Small molecule inhibitors as countermeasures for botulinum neurotoxin intoxicationBing Li, Norton P Peet, Michelle M Butler, et al.
Journal of Biomolecular Screening|May 24, 2011
Development and application of a cellular, gain-of-signal, bioluminescent reporter screen for inhibitors of type II secretion in Pseudomonas aeruginosa and Burkholderia pseudomalleiDonald T Moir, Ming Di, Erica Wong, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Drug Targets. Infectious Disorders|September 27, 2005
Identification of inhibitors of bacterial enoyl-acyl carrier protein reductaseDonald T Moir
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2016
Beyond Antibiotics: New Therapeutic Approaches for Bacterial InfectionsAlan R Hauser, Joan Mecsas, Donald T Moir
Expert Opinion on Therapeutic Targets|July 30, 2003
Microbial pathogen genomes - new strategies for identifying therapeutic and vaccine targetsTimothy Opperman, Losee L Ling, Donald T Moir
Current Opinion in Pharmacology|July 31, 2012
New classes of antibioticsDonald T Moir, Timothy J Opperman, Michelle M Butler, et al.
Journal of Bacteriology|October 22, 2008
An essential DnaB helicase of Bacillus anthracis: identification, characterization, and mechanism of actionEsther E Biswas, Marjorie H Barnes, Donald T Moir, et al.
Drug Discovery Today|April 12, 2021
Adjunctive therapy for multidrug-resistant bacterial infections: Type III secretion system and efflux inhibitorsDonald T Moir, Timothy J Opperman, Zachary D Aron, et al.
Journal of Biomolecular Screening|July 24, 2007
A high-throughput, homogeneous, bioluminescent assay for Pseudomonas aeruginosa gyrase inhibitors and other DNA-damaging agentsDonald T Moir, Ming Di, Timothy Opperman, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 6, 2009
Cellular reporter screens for inhibitors of Burkholderia pseudomallei targets in Pseudomonas aeruginosaDonald T Moir, Ming Di, Richard A Moore, et al.
Molecules (Basel, Switzerland)|January 4, 2011
Small molecule inhibitors as countermeasures for botulinum neurotoxin intoxicationBing Li, Norton P Peet, Michelle M Butler, et al.
Journal of Biomolecular Screening|May 24, 2011
Development and application of a cellular, gain-of-signal, bioluminescent reporter screen for inhibitors of type II secretion in Pseudomonas aeruginosa and Burkholderia pseudomalleiDonald T Moir, Ming Di, Erica Wong, et al.
Pageof 4